AbbVie | ABBV - Eps Gewinn Pro Aktie

Aktienkurs
204.05
Täglich Wechseln
-2.64 -1.28%
Monatlich
-10.29%
Jährlich
16.16%
Q2 Prognose
202.55

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 3.01 2.46 Apr/29
FY2025Q4 Dec/2025 2.71 3.35 2.16 Feb/04
FY2025Q3 Sep/2025 1.86 3.26 3.00 Oct/31
FY2025Q2 Jun/2025 2.97 3.21 2.65 Jul/31
FY2025Q1 Mar/2025 2.46 2.57 2.31 Apr/25




Eps Veränderung Datum
AbbVie USD 2.71 0.85 2025-12
Abbott USD 1.5 0.2 2025-12
ALKERMES USD 0.29 0.2 2025-12
Amgen USD 5.29 0.35 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Coherus Biosciences USD -0.43 0.06 2025-12
Eisai JPY 60.94 24.92 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Infinity Pharmaceuticals USD -0.11 0.01 2023-06
J&J USD 2.46 0.34 2025-12
Medtronic USD 1.36 0.29 2026-01
Merck USD 2.04 0.54 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 1.54 0.5 2025-12
Pacira USD 0.06 0.64 2025-12
Perrigo USD 0.77 0.03 2025-12
Pfizer USD 0.66 0.21 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.53 1.38 2025-12
UCB EUR 5.65 3.21 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12
Zoetis USD 1.48 0.22 2025-12